InnoBiotech that focused on the discovery, development and commercialization of antibodies for the treatments of cancer. InnoBiotech's mission is to accelerate the developmentof antibody therapies for the benefitof cancer patients.
FIND OUT MORE
PC-AB-009, is a humanized antibody therapeutic that against gastric cell surface protein CLDN18.2 highly selective and stably overexpressed during the development of various malignant tumors.
FIND OUT MORE
PC-BISAB-011 is a bispecific human monoclonal antibody targeting human B cell maturation antigen (BCMA) and CD3, which recruit T cells to the vicinity of tumor cells and activate them to attack the tumor cells.
FIND OUT MORE
An international group of individuals with diverse backgrounds, perspectives and experiences who bring considerable breadth of experience to InnoBiotech.
The united team of InnoBiotech possesses not only professional quality and utter devotion but also a strong sense of responsibility.